Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
New molecular information could help develop more effective treatments for melanoma

New molecular information could help develop more effective treatments for melanoma

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

Preclinical study unlocks the promise of CAR T-cell therapy for treatment of solid tumors

Computer simulation model helps understand why chemotherapy resistance occurs

Computer simulation model helps understand why chemotherapy resistance occurs

New combination of drugs effective against T-cell acute lymphoblastic leukemia

New combination of drugs effective against T-cell acute lymphoblastic leukemia

Cellular "barcoding" in mice unravels the origins of blood

Cellular "barcoding" in mice unravels the origins of blood

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

Treatment with immunity-boosting protein enhances the function of CAR-T cells in fighting blood cancers

Creating CAR T cells without an immune brake

Creating CAR T cells without an immune brake

Research reveals how highly proliferative leukemia cells turn into normal harmless ones

Research reveals how highly proliferative leukemia cells turn into normal harmless ones

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Children with leukemia have higher survival than adolescents and young adults with the same cancer

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Addressing the ‘trust factor’: South Carolina researchers tackle health disparities using genetics

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

Genetically engineered immune cells target cancer cells that may be responsible for leukemia relapse

New study uncovers the impact of genetic mutations on lifelong blood cell production

New study uncovers the impact of genetic mutations on lifelong blood cell production

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Aging does not influence liver renewal, research shows

Aging does not influence liver renewal, research shows

Risk factors for COVID-19 in patients with hematological malignancies

Risk factors for COVID-19 in patients with hematological malignancies

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

HMA therapy for patients with myelodysplastic syndrome could potentially activate a sleeping oncogene

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.